Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin Plus Fenofibric Acid in the Reduction of Intermediate

NCT01030328 is registered in ClinicalTrials.gov with Piedmont Healthcare as lead sponsor.

NCT NCT01030328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01030328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin Plus Fenofibric Acid in the Reduction of Intermediate
Lead sponsor
Piedmont Healthcare
Phase
Phase 3
Overall status
Withdrawn
Start date
November 30, 2009
Completion date
July 31, 2011
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary atherosclerosis